Ye Hua
General Counsel bei Hutchison MediPharma Ltd.
Profil
Ye Hua is currently a Senior Vice President & Head-Regulatory Affairs at Hutchison MediPharma Ltd.
Prior to this, he worked as a Senior Director-Global Clinical Development at Celgene Corp.
from 2011 to 2014.
He also worked as a Medical Director at Novartis Pharmaceuticals Corp.
and as a Senior VP & Head-Regulatory Affairs at HUTCHMED (China) Ltd.
Additionally, he worked as a Principal at The Shanghai Cancer Institute.
Dr. Hua received his undergraduate degree from McGill University in 1999 and another undergraduate degree from Shanghai Medical College of Fudan University in 1992.
Aktive Positionen von Ye Hua
| Unternehmen | Position | Beginn |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | General Counsel | - |
Ehemalige bekannte Positionen von Ye Hua
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2014 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| HUTCHMED (CHINA) LIMITED | General Counsel | - |
| The Shanghai Cancer Institute | Corporate Officer/Principal | - |
Ausbildung von Ye Hua
| McGill University | Undergraduate Degree |
| Shanghai Medical College of Fudan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| The Shanghai Cancer Institute |
